3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Breast Neoplasms
4
Warts
2
Pancreatic Neoplasms
2
Pain, Postoperative
2
Pain
2
Lung Neoplasms
2
Trauma, Nervous System
1
Thrombosis
1
Synovial Cyst
1
Spondylosis
1
Spondylolisthesis
1
Spinal Stenosis
1
Sleep Initiation and Maintenance Disorders
1
Sleep Deprivation
1
Schwannomatosis
1
Radiculopathy
1
Postoperative Complications
1
Papillomavirus Infections
1
Ovarian Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Neurilemmoma
1
Multiple Myeloma
1
Metastatic Non-Squamous Non-Small Cell Lung Cancer
1
Mesothelioma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Follicular
1
Lymphoma
1
Lipoma
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Intracranial Hemorrhages
1
Interventions
plerixafor
1
gamma-Globulins
1
Trimethoprim, Sulfamethoxazole Drug Combination
1
Saline Solution
1
Immunoglobulins
1
Hizentra
1
Clavulanic Acid
1
Ciprofloxacin
1
Amoxicillin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Agammaglobulinemia
×
Saline Solution
×
Clear all
NCT05645107
2026-04-13
EXCELL
Grifols Therapeutics LLC
Phase 3
Recruiting
386 enrolled